Also known as آسٹیوپوروسس مینجمنٹ
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (London), MRCPS (Glasgow), MRCP (Edinburgh)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (London), MRCPS (Glasgow), MRCP (Edinburgh)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.D
Hepatologist
MBBS (K.E), MD (USA), FCPS (Gastroenterology)
General Physician
MBBS, MCPS
Gastroenterologist
MBBS, MRCP UK, MRCP Ireland
Internal Medicine Specialist
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures